{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:27:47Z","timestamp":1794860867067,"version":"4.9.1"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_215134"],"award-info":[{"award-number":["310030_215134"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["32ER30_187505"],"award-info":[{"award-number":["32ER30_187505"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.atherosclerosis.2024.119091","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T19:02:01Z","timestamp":1734030121000},"page":"119091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Sphingoid Base Diversity"],"prefix":"10.1016","volume":"401","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4218-1087","authenticated-orcid":false,"given":"Thorsten","family":"Hornemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2024.119091_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1194\/jlr.M072421","article-title":"Cytotoxic 1-deoxysphingolipids are metabolized by a cytochrome P450-dependent pathway","volume":"58","author":"Alecu","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/iub.319","article-title":"Mammalian ceramide synthases","volume":"62","author":"Levy","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158291","article-title":"Correlations between skin condition parameters and ceramide profiles in the stratum corneum of healthy individuals","volume":"25","author":"Akiyama","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib5","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.biochi.2009.04.001","article-title":"Ceramide biosynthesis in keratinocyte and its role in skin function","volume":"91","author":"Mizutani","year":"2009","journal-title":"Biochimie"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41594-020-00551-9","article-title":"Structural insights into the regulation of human serine palmitoyltransferase complexes","volume":"28","author":"Wang","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib25","doi-asserted-by":"crossref","first-page":"37275","DOI":"10.1074\/jbc.M608066200","article-title":"Cloning and initial characterization of a new subunit for mammalian serine-palmitoyltransferase","volume":"281","author":"Hornemann","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-981-19-0394-6_4","article-title":"Serine palmitoyltransferase subunit 3 and metabolic diseases","volume":"1372","author":"Lone","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib78","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.atherosclerosis.2015.03.011","article-title":"Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography","volume":"240","author":"Othman","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib8","doi-asserted-by":"crossref","first-page":"26322","DOI":"10.1074\/jbc.M109.023192","article-title":"The SPTLC3 subunit of serine palmitoyltransferase generates short chain sphingoid bases","volume":"284","author":"Hornemann","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/CIRCULATIONAHA.123.066879","article-title":"SPTLC3 is essential for complex I activity and contributes to ischemic cardiomyopathy","volume":"150","author":"Kovilakath","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib10","doi-asserted-by":"crossref","first-page":"18429","DOI":"10.1074\/jbc.M111.296947","article-title":"Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction","volume":"287","author":"Lee","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib11","doi-asserted-by":"crossref","first-page":"10144","DOI":"10.1074\/jbc.M113.451526","article-title":"Topological and functional characterization of the ssSPTs, small activating subunits of serine palmitoyltransferase","volume":"288","author":"Harmon","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib12","doi-asserted-by":"crossref","first-page":"15591","DOI":"10.1073\/pnas.2002391117","article-title":"Subunit composition of the mammalian serine-palmitoyltransferase defines the spectrum of straight and methyl-branched long-chain bases","volume":"117","author":"Lone","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jbior.2018.08.002","article-title":"Orm\/ORMDL proteins: gate guardians and master regulators","volume":"70","author":"Davis","year":"2018","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2019.100988","article-title":"Mammalian sphingoid bases: biophysical, physiological and pathological properties","volume":"75","author":"Carreira","year":"2019","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib15","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1194\/jlr.R800012-JLR200","article-title":"Biodiversity of sphingoid bases (\"sphingosines\") and related amino alcohols","volume":"49","author":"Pruett","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1194\/jlr.M300005-JLR200","article-title":"Characterization of free endogenous C14 and C16 sphingoid bases from Drosophila melanogaster","volume":"45","author":"Fyrst","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib17","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1039\/C6SC04831E","article-title":"Structure and conserved function of iso-branched sphingoid bases from the nematode Caenorhabditis elegans","volume":"8","author":"Hannich","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib18","doi-asserted-by":"crossref","first-page":"15591","DOI":"10.1073\/pnas.2002391117","article-title":"Subunit composition of the mammalian serine-palmitoyltransferase defines the spectrum of straight and methyl-branched long-chain bases","volume":"117","author":"Lone","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrendo.2014.171","article-title":"Branched-chain amino acids in metabolic signalling and insulin resistance","volume":"10","author":"Lynch","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1203\/00006450-199104000-00015","article-title":"Accumulation of odd-numbered long-chain fatty acids in fetuses and neonates with inherited disorders of propionate metabolism","volume":"29","author":"Wendel","year":"1991","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib21","doi-asserted-by":"crossref","first-page":"20563","DOI":"10.1074\/jbc.M116.747717","article-title":"Novel mouse models of methylmalonic Aciduria recapitulate phenotypic traits with a genetic dosage effect","volume":"291","author":"Forny","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib22","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41589-018-0132-2","article-title":"Enzyme promiscuity drives branched-chain fatty acid synthesis in adipose tissues","volume":"14","author":"Wallace","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib23","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.1073\/pnas.0811269106","article-title":"Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities","volume":"106","author":"Han","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib24","doi-asserted-by":"crossref","first-page":"12962","DOI":"10.1073\/pnas.1516733112","article-title":"Elevation of 20-carbon long chain bases due to a mutation in serine palmitoyltransferase small subunit b results in neurodegeneration","volume":"112","author":"Zhao","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib26","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1074\/jbc.M808798200","article-title":"Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animals","volume":"284","author":"Zitomer","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib27","doi-asserted-by":"crossref","first-page":"11178","DOI":"10.1074\/jbc.M109.092973","article-title":"Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids","volume":"285","author":"Penno","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1042\/bj1960149","article-title":"Effects of high-fat diets on hepatic fatty acid oxidation in the rat. Isolation of rat liver peroxisomes by vertical-rotor centrifugation by using a self-generated, iso-osmotic, Percoll gradient","volume":"196","author":"Neat","year":"1981","journal-title":"Biochem. J."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1042\/bj2680765","article-title":"Induction of cytochrome P450III and P450IV family proteins in streptozotocin-induced diabetes","volume":"268","author":"Barnett","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/952734","article-title":"PPAR\/RXR regulation of fatty acid metabolism and fatty acid omega-hydroxylase (CYP4) isozymes: implications for prevention of lipotoxicity in fatty liver disease","volume":"2009","author":"Hardwick","year":"2009","journal-title":"PPAR Res."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib31","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1212\/WNL.0b013e318295d789","article-title":"Hereditary sensory and autonomic neuropathy type 1 (HSANI) caused by a novel mutation in SPTLC2","volume":"80","author":"Murphy","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib32","article-title":"An iPSC model of hereditary sensory neuropathy-1 reveals L-serine-responsive deficits in neuronal ganglioside composition and axoglial interactions","volume":"2","author":"Clark","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12017-015-8379-1","article-title":"The variant p.(Arg183Trp) in SPTLC2 causes late-onset hereditary sensory neuropathy","volume":"18","author":"Suriyanarayanan","year":"2016","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib33","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/hmg\/ddv611","article-title":"HSAN1 mutations in serine palmitoyltransferase reveal a close structure-function-phenotype relationship","volume":"25","author":"Bode","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ajhg.2010.09.010","article-title":"Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I","volume":"87","author":"Rotthier","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib36","doi-asserted-by":"crossref","first-page":"E2211","DOI":"10.1002\/humu.21481","article-title":"Characterization of two mutations in the SPTLC1 subunit of serine palmitoyltransferase associated with hereditary sensory and autonomic neuropathy type I","volume":"32","author":"Rotthier","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1194\/jlr.M068676","article-title":"Localization of 1-deoxysphingolipids to mitochondria induces mitochondrial dysfunction","volume":"58","author":"Alecu","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100122","article-title":"Metabolism of HSAN1- and T2DM-associated 1-deoxy-sphingolipids inhibits the migration of fibroblasts","volume":"62","author":"Karsai","year":"2021","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101716","article-title":"Divergent amino acid and sphingolipid metabolism in patients with inherited neuro-retinal disease","volume":"72","author":"Green","year":"2023","journal-title":"Mol Metab"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib41","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMoa1815111","article-title":"Serine and lipid metabolism in macular disease and peripheral neuropathy","volume":"381","author":"Gantner","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib40","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41586-020-2609-x","article-title":"Serine restriction alters sphingolipid diversity to constrain tumour growth","volume":"586","author":"Muthusamy","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib42","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41591-021-01346-1","article-title":"Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis","volume":"27","author":"Mohassel","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib43","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2337\/db14-1325","article-title":"Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats","volume":"64","author":"Othman","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib44","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/ene.12663","article-title":"Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?","volume":"22","author":"Dohrn","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib45","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/j.pain.0000000000002580","article-title":"Deoxy-sphingolipids, oxidative stress, and vitamin C correlate with qualitative and quantitative patterns of small fiber dysfunction and degeneration","volume":"163","author":"Dohrn","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41586-022-05637-6","article-title":"Insulin-regulated serine and lipid metabolism drive peripheral neuropathy","volume":"614","author":"Handzlik","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib47","article-title":"AdipoAtlas: a reference lipidome for human white adipose tissue","volume":"2","author":"Lange","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0304-3835(99)00428-0","article-title":"The marine compound spisulosine, an inhibitor of cell proliferation, promotes the disassembly of actin stress fibers","volume":"152","author":"Cuadros","year":"2000","journal-title":"Cancer Lett."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib49","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1172\/JCI57549","article-title":"Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1","volume":"121","author":"Garofalo","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ejphar.2008.02.011","article-title":"Spisulosine (ES-285) induces prostate tumor PC-3 and LNCaP cell death by de novo synthesis of ceramide and PKCzeta activation","volume":"584","author":"Sanchez","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib51","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10495-006-0573-z","article-title":"The marine sphingolipid-derived compound ES 285 triggers an atypical cell death pathway","volume":"12","author":"Salcedo","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2018.05.008","article-title":"Hereditary sensory neuropathy type 1-associated deoxysphingolipids cause neurotoxicity, acute calcium handling abnormalities and mitochondrial dysfunction in vitro","volume":"117","author":"Wilson","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib53","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neuropharm.2016.03.033","article-title":"1-Deoxysphingolipid-induced neurotoxicity involves N-methyl-d-aspartate receptor signaling","volume":"110","author":"Guntert","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib54","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.bpj.2014.10.010","article-title":"Biophysical properties of novel 1-deoxy-(dihydro)ceramides occurring in mammalian cells","volume":"107","author":"Jimenez-Rojo","year":"2014","journal-title":"Biophys. J."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib55","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1194\/jlr.M067033","article-title":"Elucidating the chemical structure of native 1-deoxysphingosine","volume":"57","author":"Steiner","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib56","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1194\/jlr.M058750","article-title":"Regulation of mitochondrial ceramide distribution by members of the BCL-2 family","volume":"56","author":"Zhang","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib57","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1096\/fj.201902645R","article-title":"Biosynthesis of the anti-lipid-microdomain sphingoid base 4,14-sphingadiene by the ceramide desaturase FADS3","volume":"34","author":"Jojima","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib58","article-title":"Metabolism of sphingadiene and characterization of the sphingadiene-producing enzyme FADS3","volume":"1868","author":"Jojima","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib59","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1074\/jbc.AC119.011883","article-title":"FADS3 is a Delta14Z sphingoid base desaturase that contributes to gender differences in the human plasma sphingolipidome","volume":"295","author":"Karsai","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib60","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/s41431-019-0444-z","article-title":"DEGS1 variant causes neurological disorder","volume":"27","author":"Dolgin","year":"2019","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib61","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI124159","article-title":"DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans","volume":"129","author":"Karsai","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib62","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1172\/JCI123959","article-title":"Loss of the sphingolipid desaturase DEGS1 causes hypomyelinating leukodystrophy","volume":"129","author":"Pant","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101236","article-title":"The pathophysiological role of dihydroceramide desaturase in the nervous system","volume":"91","author":"Tzou","year":"2023","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100464","article-title":"The atypical sphingolipid SPB 18:1(14Z);O2 is a biomarker for DEGS1 related hypomyelinating leukodystrophy","author":"Hulsmeier","year":"2023","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-1-0716-4116-3_14","article-title":"Long chain base profiling with multiple reaction monitoring mass spectrometry","volume":"2855","author":"Hulsmeier","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000672","article-title":"Genetic determinants of circulating sphingolipid concentrations in European populations","volume":"5","author":"Hicks","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib67","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ng.507","article-title":"A genome-wide perspective of genetic variation in human metabolism","volume":"42","author":"Illig","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002490","article-title":"Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations","volume":"8","author":"Demirkan","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib69","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib70","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1038\/s41467-019-11954-8","article-title":"Genetic architecture of human plasma lipidome and its link to cardiovascular disease","volume":"10","author":"Tabassum","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib71","doi-asserted-by":"crossref","first-page":"172","DOI":"10.12997\/jla.2020.9.1.172","article-title":"Genetic architecture of circulating very-long-chain (C24:0 and C22:0) ceramide concentrations","volume":"9","author":"Cresci","year":"2020","journal-title":"J Lipid Atheroscler"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib72","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/hmg\/ddab002","article-title":"Heritability and family-based GWAS analyses of the N-acyl ethanolamine and ceramide plasma lipidome","volume":"30","author":"McGurk","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib73","doi-asserted-by":"crossref","first-page":"13397","DOI":"10.1074\/jbc.M112.428185","article-title":"Myristate-derived d16:0 sphingolipids constitute a cardiac sphingolipid pool with distinct synthetic routes and functional properties","volume":"288","author":"Russo","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib74","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.metabol.2012.05.004","article-title":"SNPs affecting serum metabolomic traits may regulate gene transcription and lipid accumulation in the liver","volume":"61","author":"Mirkov","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-19-0394-6_1","article-title":"Sphingolipids and cholesterol","volume":"1372","author":"Jiang","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib76","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1126\/science.1174621","article-title":"Lipid rafts as a membrane-organizing principle","volume":"327","author":"Lingwood","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib77","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.plipres.2010.03.003","article-title":"Sterols and sphingolipids: dynamic duo or partners in crime?","volume":"49","author":"Gulati","year":"2010","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib79","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1021\/acschemneuro.9b00532","article-title":"Spatial lipidomics reveals region and long chain base specific accumulations of monosialogangliosides in amyloid plaques in familial alzheimer's disease mice (5xFAD) brain","volume":"11","author":"Kaya","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib80","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3892\/mco.2021.2488","article-title":"Serine palmitoyltransferase long chain subunit 3 is associated with hepatocellular carcinoma in patients with NAFLD","volume":"16","author":"Ijuin","year":"2022","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib81","doi-asserted-by":"crossref","first-page":"13538","DOI":"10.1074\/jbc.M709950200","article-title":"Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1","volume":"283","author":"Shah","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib82","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.26606","article-title":"Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides","volume":"59","author":"Cinar","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib83","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3892\/or.2015.3745","article-title":"Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis","volume":"33","author":"Yoshimine","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/nu11051185","article-title":"Sulforaphane prevents hepatic insulin resistance by blocking serine palmitoyltransferase 3-mediated ceramide biosynthesis","volume":"11","author":"Teng","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib85","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/aps.2017.127","article-title":"Omega-3 PUFA ameliorates hyperhomocysteinemia-induced hepatic steatosis in mice by inhibiting hepatic ceramide synthesis","volume":"38","author":"Dong","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib86","article-title":"Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence","volume":"5","author":"Chew","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib87","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1212\/WNL.0000000000006811","article-title":"Randomized trial of l-serine in patients with hereditary sensory and autonomic neuropathy type 1","volume":"92","author":"Fridman","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.atherosclerosis.2024.119091_bib88","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1038\/ncomms4083","article-title":"Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease","volume":"5","author":"Mardinoglu","year":"2014","journal-title":"Nat. Commun."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024015223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024015223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:53:59Z","timestamp":1777391639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024015223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":88,"alternative-id":["S0021915024015223"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.119091","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sphingoid Base Diversity","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.119091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119091"}}